In this study, we aimed to extend our previous work, where we tested a combination therapy directed against proteins frequently overexpressed in melanoma—EGFR (epidermal growth factor receptor) and MET (hepatocyte growth factor receptor)—in a panel of human melanoma cell lines and samples derived from patients. This evidence concerns the gene EGFR and melanoma.